2022 Q4 Form 20-F Financial Statement

#000117891323001230 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $83.13M $337.4M $79.76M
YoY Change 4.23% 13.34% 42.7%
Cost Of Revenue $15.81M $65.95M $15.21M
YoY Change 3.95% 27.5% 56.84%
Gross Profit $67.32M $271.4M $64.54M
YoY Change 4.3% 10.36% 39.76%
Gross Profit Margin 80.98% 80.45% 80.93%
Selling, General & Admin $48.21M $225.8M $55.87M
YoY Change -13.7% 8.18% 53.52%
% of Gross Profit 71.62% 83.18% 86.56%
Research & Development $21.33M $92.56M $21.83M
YoY Change -2.3% 16.73% 60.86%
% of Gross Profit 31.68% 34.1% 33.82%
Depreciation & Amortization $1.995M $10.19M $2.772M
YoY Change -28.03% 48.12% 125.37%
% of Gross Profit 2.96% 3.75% 4.29%
Operating Expenses $69.54M $346.0M $77.69M
YoY Change -10.5% 20.13% 55.51%
Operating Profit -$2.222M -$74.53M -$13.15M
YoY Change -83.11% 77.29% 247.94%
Interest Expense $1.391M $4.220M -$5.636M
YoY Change -124.68% -121.78% 34.51%
% of Operating Profit
Other Income/Expense, Net -$596.0K
YoY Change 344.78%
Pretax Income -$831.0K -$70.91M -$19.51M
YoY Change -95.74% 9.34% 144.82%
Income Tax $468.0K $577.0K $8.000K
% Of Pretax Income
Net Earnings -$1.299M -$71.49M -$19.52M
YoY Change -93.35% 9.96% 141.58%
Net Earnings / Revenue -1.56% -21.19% -24.47%
Basic Earnings Per Share -$1.94
Diluted Earnings Per Share -$0.04 -$1.94 -$543.1K
COMMON SHARES
Basic Shares Outstanding 37.54M shares 36.86M shares
Diluted Shares Outstanding 36.86M shares

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $462.0M $462.0M $323.3M
YoY Change 42.91% 42.91% -33.67%
Cash & Equivalents $86.75M $86.75M $71.15M
Short-Term Investments $241.3M $241.3M $118.2M
Other Short-Term Assets $144.2M $144.2M $130.7M
YoY Change 10.32% 10.32% 32.93%
Inventory
Prepaid Expenses
Receivables
Other Receivables $19.02M $14.29M
Total Short-Term Assets $625.2M $625.2M $468.2M
YoY Change 33.53% 33.53% -20.8%
LONG-TERM ASSETS
Property, Plant & Equipment $5.660M $14.74M $18.28M
YoY Change -69.04% -19.39% -16.52%
Goodwill $77.27M $77.27M
YoY Change 0.0%
Intangibles $14.77M $49.22M
YoY Change -69.99%
Long-Term Investments $189.8M $189.8M $317.5M
YoY Change -40.21% -40.21% 39.26%
Other Assets $1.965M $1.965M $1.055M
YoY Change 86.26% 86.26% -64.83%
Total Long-Term Assets $298.6M $298.6M $463.4M
YoY Change -35.56% -35.56% 71.61%
TOTAL ASSETS
Total Short-Term Assets $625.2M $625.2M $468.2M
Total Long-Term Assets $298.6M $298.6M $463.4M
Total Assets $923.8M $923.8M $931.6M
YoY Change -0.83% -0.83% 8.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.630M $8.630M $8.699M
YoY Change -0.79% -0.79% 141.64%
Accrued Expenses $2.755M $42.64M $3.055M
YoY Change -9.82% -9.85% -7.42%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $2.269M
YoY Change -100.0% -100.0% 278.17%
Total Short-Term Liabilities $197.1M $197.1M $189.0M
YoY Change 4.26% 4.26% 29.57%
LONG-TERM LIABILITIES
Long-Term Debt $454.3M $452.8M $385.2M
YoY Change 17.95% 21.69% 8.16%
Other Long-Term Liabilities $1.559M $8.208M $10.48M
YoY Change -85.13% -65.19% -24.58%
Total Long-Term Liabilities $461.0M $461.0M $395.7M
YoY Change 16.51% 16.51% 6.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $197.1M $197.1M $189.0M
Total Long-Term Liabilities $461.0M $461.0M $395.7M
Total Liabilities $658.1M $658.1M $584.7M
YoY Change 12.55% 12.55% 13.36%
SHAREHOLDERS EQUITY
Retained Earnings -$288.0M -$237.6M
YoY Change 21.24%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $265.7M $265.7M $346.9M
YoY Change
Total Liabilities & Shareholders Equity $923.8M $923.8M $931.6M
YoY Change -0.83% -0.83% 8.17%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income -$1.299M -$71.49M -$19.52M
YoY Change -93.35% 9.96% 141.58%
Depreciation, Depletion And Amortization $1.995M $10.19M $2.772M
YoY Change -28.03% 48.12% 125.37%
Cash From Operating Activities $9.605M $30.11M $8.245M
YoY Change 16.49% -20.83% 72.49%
INVESTING ACTIVITIES
Capital Expenditures $68.00K $1.198M -$652.0K
YoY Change -110.43% -146.47% -41.26%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities -$76.45M -$12.25M -$81.99M
YoY Change -6.75% -94.6% -68.32%
Cash From Investing Activities -$76.52M -$14.62M -$82.64M
YoY Change -7.41% -93.63% -68.21%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.028M
YoY Change -61.21%
Debt Paid & Issued, Net $2.269M
YoY Change 301.59%
Cash From Financing Activities 1.715M -$1.637M 2.634M
YoY Change -34.89% -31.71% -99.37%
NET CHANGE
Cash From Operating Activities 9.605M $30.11M 8.245M
Cash From Investing Activities -76.52M -$14.62M -82.64M
Cash From Financing Activities 1.715M -$1.637M 2.634M
Net Change In Cash -65.20M $13.82M -71.76M
YoY Change -9.14% -107.13% -144.6%
FREE CASH FLOW
Cash From Operating Activities $9.605M $30.11M $8.245M
Capital Expenditures $68.00K $1.198M -$652.0K
Free Cash Flow $9.537M $28.91M $8.897M
YoY Change 7.19% -28.81% 51.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2269000 usd
CY2022Q4 fvrr Long Term Loan And Long Term Liabilities
LongTermLoanAndLongTermLiabilities
1559000 usd
CY2021Q4 fvrr Long Term Loan And Long Term Liabilities
LongTermLoanAndLongTermLiabilities
13099000 usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
37537563 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
37537563 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
36761108 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36761108 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.94
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.81
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
36856140 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
36856140 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35955014 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35955014 shares
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32323636 shares
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32323636 shares
CY2020 fvrr Issuance Costs
IssuanceCosts
1109000 usd
CY2020 fvrr Stock Issued During Period Value New Issues1
StockIssuedDuringPeriodValueNewIssues1
129853000 usd
CY2020 fvrr Convertible Notes Issuance Costs
ConvertibleNotesIssuanceCosts
2842000 usd
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments
99190000 usd
CY2020 fvrr Stock Issued During Period Value Purchase Of Capped Call
StockIssuedDuringPeriodValuePurchaseOfCappedCall
-43240000 usd
CY2021 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
313000 usd
CY2022 fvrr Stock Issued During Period Value Cumulative Effect Of Adopting Asu
StockIssuedDuringPeriodValueCumulativeEffectOfAdoptingAsu
-78157000 usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
26000 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
13000 usd
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 usd
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
129853000 usd
CY2022 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0 usd
CY2021 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
0 usd
CY2020 us-gaap Payments For Derivative Instrument Financing Activities
PaymentsForDerivativeInstrumentFinancingActivities
43240000 usd
CY2022 us-gaap Nature Of Operations
NatureOfOperations
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><strong>Note 1: - General</strong></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Fiverr International Ltd. was incorporated on April 29, 2010, under the laws of Israel, and commenced operations on the same date.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Fiverr International Ltd. and its subsidiaries (the “Company”) operates a worldwide online marketplace for sellers to sell their services and buyers to buy them. The Company’s platform includes various categories across ten verticals, including Graphics &amp; Design, Digital Marketing, Writing &amp; Translation, Video &amp; Animation, Music &amp; Audio, Programming &amp; Tech, Business, Data, Lifestyle and photography. </span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">The Company’s platform also includes a variety of value-added products including subscription-based content marketing platform, back-office platform, learning and development offerings, creative talent platform and freelancer management platform.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt">Commencing June 13, 2019, the ordinary shares of the Company are traded on the New York Stock Exchange.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:0px;margin-bottom:0px;text-align:justify"> </div> </div>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;text-indent:18pt;margin-bottom:0pt">a.<span style="padding-left:11.06pt">Use of estimates:</span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;text-indent:18pt;margin-bottom:0pt"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px">The preparation of consolidated financial statements, in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes.</div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px">The accounting estimates that require management’s subjective judgments include but are not limited to revenue recognition, income taxes, share-based compensation, purchase price allocation on acquisitions including determination of identifiable intangible assets of useful lives convertible notes borrowing rate, contingent consideration and impairment of intangible assets. The Company evaluates its estimates and judgments on an ongoing basis and revises them when necessary. Actual results may differ from the original or revised estimates.</div> </div>
CY2022 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ad.<span style="padding-left:6.06pt">Certain comparative figures have been reclassified to conform to the current year presentation.</span></span></span>
CY2021Q4 fvrr Contingent Consideration Liability Fair Value Disclosure
ContingentConsiderationLiabilityFairValueDisclosure
13858000 usd
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;text-indent:18pt;margin-bottom:0px">n.<span style="padding-left:10.5pt">Concentrations of credit risks:</span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;text-indent:18pt;margin-bottom:0px"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, bank deposits, investment in marketable securities, restricted deposit and derivatives, which are placed in major banks in Israel, Germany and the U.S.</p> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px">User funds are held by a payment service provider which, pursuant to the agreement, was engaged to hold the user funds on behalf of buyers and sellers in an account segregated from the payment service provider’s operating bank account.</div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;padding-left:36pt;margin-bottom:0px"> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0px;text-indent:36pt;margin-bottom:0px">The Company does not have off-balance sheet concentration of credit risks.</div> </div>
CY2022 fvrr Business Combination Contingent Consideration Liability Arise During Year
BusinessCombinationContingentConsiderationLiabilityAriseDuringYear
1609000 usd
CY2022 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
12249000 usd
CY2022Q4 fvrr Contingent Consideration Liability Fair Value Disclosure
ContingentConsiderationLiabilityFairValueDisclosure
0 usd
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6386203 shares
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5840619 shares
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6017362 shares
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13265000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12265000 usd
CY2020 us-gaap Depreciation
Depreciation
1207000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
1600000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1444000 usd
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
4000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2275000 usd
CY2020Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
460000000 usd
CY2020Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0 pure
CY2020Q4 fvrr Debt Instrument Convertible Initial Conversion Rate
DebtInstrumentConvertibleInitialConversionRate
4.6823
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2020Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
213.57
CY2020Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2025-11-01
CY2020Q4 us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
Prior t
CY2020Q4 us-gaap Debt Instrument Redemption Period End Date
DebtInstrumentRedemptionPeriodEndDate
2023-11-05
CY2020Q4 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
1.30 pure
CY2020Q4 us-gaap Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
20 days
CY2020Q4 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
30 days
CY2020Q4 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1 pure
CY2020Q4 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
9969000 usd
CY2020Q4 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2842000 usd
CY2020Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.051 pure
CY2022Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0056 pure
CY2022Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
460000000 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
460000000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
0 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
85478000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
7236000 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
2446000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
452764000 usd
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
372076000 usd
CY2022Q4 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
0 usd
CY2021Q4 us-gaap Debt Instrument Convertible Carrying Amount Of The Equity Component
DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent
99190000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
560060 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
61.91
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
282479 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.99
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
89965 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
83.29
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
19473000 usd
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3677000 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2527000 usd
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
556000 usd
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
359000 usd
CY2022 us-gaap Interest Expense Debt
InterestExpenseDebt
2527000 usd
CY2021 us-gaap Interest Expense Debt
InterestExpenseDebt
20029000 usd
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
4036000 usd
CY2022Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 usd
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
12258000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1559000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
841000 usd
CY2022Q4 fvrr Long Term Loan And Long Term Liabilities
LongTermLoanAndLongTermLiabilities
1559000 usd
CY2021Q4 fvrr Long Term Loan And Long Term Liabilities
LongTermLoanAndLongTermLiabilities
13099000 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2908598 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
47.85
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y14D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3096214 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
52.54
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M7D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2176521 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
32.85
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y25D
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
25.24
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
130.95
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
27.85
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
10873000 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
142419000 usd
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
128463000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
23346000 usd
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
25536000 usd
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
12620000 usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
71755000 usd
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55407000 usd
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15815000 usd
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
144610000 usd
CY2022 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M18D
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
61779000 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
36490000 usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 usd
CY2022Q4 fvrr Deferred Tax Assets Issuance Costs
DeferredTaxAssetsIssuanceCosts
0 usd
CY2021Q4 fvrr Deferred Tax Assets Issuance Costs
DeferredTaxAssetsIssuanceCosts
630000 usd
CY2022Q4 fvrr Total Deferred Tax Assets Liabilities Net Before Valuation Allowance
TotalDeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
61779000 usd
CY2021Q4 fvrr Total Deferred Tax Assets Liabilities Net Before Valuation Allowance
TotalDeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
36490000 usd
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.24 pure
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.25 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.23 pure
CY2017Q1 fvrr Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Preferred Enterprises Located In Development Area Percent
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePreferredEnterprisesLocatedInDevelopmentAreaPercent
0.075 pure
CY2017 fvrr Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Preferred Enterprises Located In Development Area Percent
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePreferredEnterprisesLocatedInDevelopmentAreaPercent
0.09 pure
CY2018 fvrr Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate Preferred Enterprises Located In Other Than Development Area Percent
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRatePreferredEnterprisesLocatedInOtherThanDevelopmentAreaPercent
0.16 pure

Files In Submission

Name View Source Status
fvrr-20221231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
0001178913-23-001230-index-headers.html Edgar Link pending
0001178913-23-001230-index.html Edgar Link pending
0001178913-23-001230.txt Edgar Link pending
0001178913-23-001230-xbrl.zip Edgar Link pending
exhibit_12-1.htm Edgar Link pending
exhibit_12-2.htm Edgar Link pending
exhibit_13-1.htm Edgar Link pending
exhibit_13-2.htm Edgar Link pending
exhibit_15-1.htm Edgar Link pending
exhibit_2-1.htm Edgar Link pending
exhibit_8-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fvrr-20221231.xsd Edgar Link pending
image00011.jpg Edgar Link pending
img01.jpg Edgar Link pending
img02.jpg Edgar Link pending
img03.jpg Edgar Link pending
img04.jpg Edgar Link pending
img05.jpg Edgar Link pending
img06.jpg Edgar Link pending
img07.jpg Edgar Link pending
img09.jpg Edgar Link pending
img10.jpg Edgar Link pending
img11.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
fvrr-20221231_pre.xml Edgar Link unprocessable
fvrr-20221231_lab.xml Edgar Link unprocessable
fvrr-20221231_cal.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zk2329264.htm Edgar Link pending
zk2329264_htm.xml Edgar Link completed